U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Olivomycin is an antitumor glycoside antibiotic that binds to DNA. This drug is used to treat testicular neoplasms, tonsillar tumors and reticulosarcoma with peripheral nodes. In addition, olivomycin was studied for the diagnosis of ureaplasma infection of the sperm.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
[The effect of olivomycin on the spontaneous regression of experimental atherosclerosis in rabbits of different ages].
1997
[Use of olivomycin for the diagnosis of Ureaplasma infection of the sperm].
1988-07
[Effect of a protein synthesis inhibitor (olivomycin) on the development of experimental atherosclerosis in rabbits].
1987-07-01
[Use of olivomycin in the treatment of cancer of the uterine cervix].
1976

Sample Use Guides

In Vivo Use Guide
first injection: 0,002–0,003 g, then dosage increases up to 0,015 g.
Route of Administration: Intravenous
Substance Class Mixture
Created
by admin
on Mon Mar 31 22:02:25 GMT 2025
Edited
by admin
on Mon Mar 31 22:02:25 GMT 2025
Record UNII
44003517D1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-76411
Preferred Name English
OLIVOMYCIN
INN   WHO-DD  
INN  
Official Name English
Olivomycin [WHO-DD]
Common Name English
OLIVOMYCINS [MI]
Common Name English
olivomycin [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C259
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
NCI_THESAURUS C2115
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
Code System Code Type Description
PUBCHEM
3084072
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
EVMPD
SUB03507MIG
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
FDA UNII
44003517D1
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
SMS_ID
100000085937
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
NCI_THESAURUS
C715
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108548
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
CAS
11006-70-5
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
EPA CompTox
DTXSID90891343
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
INN
2435
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
MERCK INDEX
m8202
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY Merck Index
NSC
76411
Created by admin on Mon Mar 31 22:02:25 GMT 2025 , Edited by admin on Mon Mar 31 22:02:25 GMT 2025
PRIMARY
All of the following components must be present:
Structure of OLIVOMYCIN B
Structure of OLIVOMYCIN C
Structure of OLIVOMYCIN A
Structure of OLIVOMYCIN D
Related Record Type Details
OLIVOMYCIN
ACTIVE MOIETY
Definition References
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966